Roche Holding AG (RHHBY)
Sector: Drug Manufacturers - General
Industry: Drug Manufacturers - General
Roche Holding AG
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 60.17 | 60.91 | 60.12 | 60.25 | 2,126,965 |
| Nov 16, 2026 | 60.99 | 61.27 | 60.80 | 60.95 | 1,544,131 |
| Nov 13, 2026 | 60.15 | 60.49 | 60.05 | 60.30 | 617,955 |
| Nov 12, 2026 | 60.75 | 60.98 | 60.47 | 60.50 | 977,801 |
| Nov 11, 2026 | 60.01 | 60.70 | 59.87 | 60.57 | 724,682 |
| Nov 10, 2026 | 60.96 | 61.22 | 60.58 | 61.08 | 723,757 |
| Nov 9, 2026 | 60.81 | 61.75 | 60.49 | 61.32 | 861,205 |
| Nov 6, 2026 | 58.32 | 59.61 | 58.20 | 59.37 | 1,096,381 |
| Nov 5, 2026 | 59.76 | 60.40 | 59.33 | 59.45 | 981,495 |
| Nov 4, 2026 | 60.28 | 61.04 | 59.88 | 60.94 | 1,118,542 |
| Nov 3, 2026 | 60.43 | 60.58 | 59.13 | 59.18 | 1,132,298 |
| Nov 2, 2026 | 60.48 | 60.76 | 60.22 | 60.67 | 2,091,787 |
| Oct 30, 2026 | 61.10 | 61.44 | 60.75 | 61.27 | 1,523,441 |
| Oct 29, 2026 | 60.56 | 61.03 | 60.51 | 60.77 | 1,148,667 |
| Oct 28, 2026 | 59.46 | 60.28 | 59.39 | 60.22 | 1,274,744 |
| Oct 27, 2026 | 59.42 | 60.37 | 59.41 | 60.37 | 2,544,554 |
| Oct 26, 2026 | 59.82 | 60.15 | 59.70 | 59.98 | 3,624,604 |
| Oct 23, 2026 | 59.53 | 61.49 | 59.00 | 61.17 | 2,699,576 |
| Oct 22, 2026 | 58.65 | 59.83 | 58.41 | 59.62 | 979,287 |
| Oct 21, 2026 | 59.14 | 59.49 | 58.83 | 59.11 | 1,353,176 |
Roche Holding AG functions as a major global healthcare enterprise, primarily concentrating its efforts within the pharmaceutical and diagnostic sectors.
The company boasts an extensive international presence, with key operations located in countries such as Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, and Belgium.
Its pharmaceutical division is dedicated to creating and supplying a diverse array of therapeutic remedies. These target a broad spectrum of medical fields, including oncology, neuroscience, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments. The comprehensive product line further extends to treatments for specific conditions like infectious diseases, anemia, various dermatological issues, hemophilia, inflammatory and autoimmune disorders, neurological conditions, and transplantation-related needs. Within its diagnostics segment, Roche develops and markets a wide variety of laboratory-based tests designed to identify and monitor numerous illnesses. These include, but are not limited to, cancer, diabetes, Covid-19, hepatitis, and human papillomavirus.
Additionally, the company is a provider of essential diagnostic instruments and reagents. Established in 1896, Roche Holding AG maintains its corporate headquarters in Basel, Switzerland.
based on 6.37B shares outstanding
30d Avg
1.44M
60d Avg
1.45M
90d Avg
1.68M
1 member of Congress disclosed 1 trade in RHHBY with transaction dates in the 180 days to Nov 18, 2026. Roche Holding AG (OTC: RHHBY) traded at $60.25 on Nov 17, 2026, down 1.15% from the previous close of $60.95. 52-week range: $47.05 to $61.75. The company is in the Healthcare sector (Drug Manufacturers - General).
More RHHBY data
Learn more
- Politicians who traded RHHBY
- Bruce Westerman
- Josh Gottheimer
- Ritchie Torres
- Ro Khanna